Trial Condition(s):

Hysterectomy

Proportion of hysterectomy after female sterilization

Bayer Identifier:

18473

ClinicalTrials.gov Identifier:

NCT02532361

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

The objective of this study is to describe the proportion of hysterectomy in patients that had undergone sterilization through hysteroscopic device placement and the patients that had undergone sterilization through tubal ligation.

Inclusion Criteria
- Age: 18 to 49 years at index date 
                - Gender: Female 
                - Diagnosis: Women who underwent hysteroscopic device sterilization procedure
                   - Diagnosis: Women who underwent tubal ligation sterilization procedure (includes laparoscopic tubal ligation), and salpingectomy
Exclusion Criteria
- Patients undergoing in-vitro fertilization (IVF) procedures 
               - Embryo transfer, intrauterine
               - Follicle puncture for oocyte retrieval, any method

Trial Summary

Enrollment Goal
10578
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Essure (ESS305, BAY1454032)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Locations
Locations

Investigative Site

New Jersey, United States

Trial Design